SCHEMBL8309634

SCHEMBL8309634

O=C(c1ccccc1)c1ccc(Nc2ncnc3ccc(OCCBr)cc23)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 5/20 0.55
HDAC4 P56524 5/20 0.55
HDAC1 Q13547 5/20 0.55
HDAC7 Q8WUI4 5/20 0.55
HDAC2 Q92769 5/20 0.55
HDAC10 Q969S8 5/20 0.55
HDAC11 Q96DB2 5/20 0.55
HDAC8 Q9BY41 5/20 0.55
HDAC6 Q9UBN7 5/20 0.55
HDAC9 Q9UKV0 5/20 0.55
HDAC5 Q9UQL6 5/20 0.55
EGFR P00533 15/20 0.54
ERBB2 P04626 7/20 0.53
FBP1 P09467 1/20 0.47
KDM4E B2RXH2 1/20 0.46
GRM4 Q14833 1/20 0.46
LCK P06239 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8309941 0.89 HDAC3 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8308835 0.86 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL8305110 0.85 EGFR (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8305842 0.83 EGFR (0.60) EGFRERBB2KDM4EGRM4
SCHEMBL8307434 0.83 EGFR (0.53) EGFRERBB2KDM4EGRM4LCK
SCHEMBL8309364 0.78 EGFR (0.70) EGFRERBB2FBP1LCK
Hydrochloric Acid SCHEMBL8305253 0.78 EGFR (0.64) EGFRGRM4
Hydrochloric Acid SCHEMBL8309441 0.78 EGFR (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL8307571 0.77 EGFR (0.69) EGFRERBB2FBP1KDM4ELCK
Hydrochloric Acid SCHEMBL8306555 0.77 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed